- •Foreword
- •Preface
- •Contributors
- •Contents
- •1. Epidemiology of Pediatric Strabismus
- •1.1 Introduction
- •1.2 Forms of Pediatric Strabismus
- •1.2.1 Esodeviations
- •1.2.1.1 Congenital Esotropia
- •1.2.1.2 Accommodative Esotropia
- •1.2.1.3 Acquired Nonaccommodative Esotropia
- •1.2.1.4 Abnormal Central Nervous System Esotropia
- •1.2.1.5 Sensory Esotropia
- •1.2.2 Exodeviations
- •1.2.2.1 Intermittent Exotropia
- •1.2.2.2 Congenital Exotropia
- •1.2.2.4 Abnormal Central Nervous System Exotropia
- •1.2.2.5 Sensory Exotropia
- •1.2.3 Hyperdeviations
- •1.3 Strabismus and Associated Conditions
- •1.4.1 Changes in Strabismus Prevalence
- •1.4.2 Changes in Strabismus Surgery Rates
- •1.5 Worldwide Incidence and Prevalence of Childhood Strabismus
- •1.6 Incidence of Adult Strabismus
- •References
- •2.1 Binocular Alignment System
- •2.1.2 Vergence Adaptation
- •2.1.3 Muscle Length Adaptation
- •2.2 Modeling the Binocular Alignment Control System
- •2.2.1 Breakdown of the Binocular Alignment Control System
- •2.2.4 Changes in Basic Muscle Length
- •2.2.6 Evidence Against the “Final Common Pathway”
- •2.3 Changes in Strabismus
- •2.3.1 Diagnostic Occlusion: And the Hazard of Prolonged Occlusion
- •2.3.2.1 Supporting Evidence for Bilateral Feedback Control of Muscle Lengths
- •2.4 Applications of Bilateral Feedback Control to Clinical Practice and to Future Research
- •References
- •3.1 Dissociated Eye Movements
- •3.2 Tonus and its relationship to infantile esotropia
- •3.5 Pathogenetic Role of Dissociated Eye Movements in Infantile Esotropia
- •References
- •4.1 Introduction
- •4.2.1 Binocular Correspondence: Anomalous, Normal, or Both?
- •4.3 MFS with Manifest Strabismus
- •4.3.1 Esotropia is the Most Common Form of MFS
- •4.3.2 Esotropia Allows for Better Binocular Vision
- •4.3.3 Esotropia is the Most Stable Form
- •4.4 Repairing and Producing MFS
- •4.4.1 Animal Models for the Study of MFS
- •References
- •5.1 Esotropia as the Major Type of Developmental Strabismus
- •5.1.2 Early Cerebral Damage as the Major Risk Factor
- •5.1.3 Cytotoxic Insults to Cerebral Fibers
- •5.1.5 Development of Binocular Visuomotor Behavior in Normal Infants
- •5.1.6 Development of Sensorial Fusion and Stereopsis
- •5.1.7 Development of Fusional Vergence and an Innate Convergence Bias
- •5.1.8 Development of Motion Sensitivity and Conjugate Eye Tracking (Pursuit/OKN)
- •5.1.9 Development and Maldevelopment of Cortical Binocular Connections
- •5.1.10 Binocular Connections Join Monocular Compartments Within Area V1 (Striate Cortex)
- •5.1.11 Too Few Cortical Binocular Connections in Strabismic Primate
- •5.1.12 Projections from Striate Cortex (Area V1) to Extrastriate Cortex (Areas MT/MST)
- •5.1.15 Persistent Nasalward Visuomotor Biases in Strabismic Primate
- •5.1.16 Repair of Strabismic Human Infants: The Historical Controversy
- •5.1.18 Timely Restoraion of Correlated Binocular Input: The Key to Repair
- •References
- •6. Neuroanatomical Strabismus
- •6.1 General Etiologies of Strabismus
- •6.2 Extraocular Myopathy
- •6.2.1 Primary EOM Myopathy
- •6.2.2 Immune Myopathy
- •6.2.4 Neoplastic Myositis
- •6.2.5 Traumatic Myopathy
- •6.3 Congenital Pulley Heterotopy
- •6.4 Acquired Pulley Heterotopy
- •6.5 “Divergence Paralysis” Esotropia
- •6.5.1 Vertical Strabismus Due to Sagging Eye Syndrome
- •6.5.2 Postsurgical and Traumatic Pulley Heterotopy
- •6.5.3 Axial High Myopia
- •6.6 Congenital Peripheral Neuropathy: The Congenital Cranial Dysinnervation Disorders (CCDDs)
- •6.6.1 Congenital Oculomotor (CN3) Palsy
- •6.6.3 Congenital Trochlear (CN4) Palsy
- •6.6.4 Duane’s Retraction Syndrome (DRS)
- •6.6.5 Moebius Syndrome
- •6.7 Acquired Motor Neuropathy
- •6.7.1 Oculomotor Palsy
- •6.7.2 Trochlear Palsy
- •6.7.3 Abducens Palsy
- •6.7.4 Inferior Oblique (IO) Palsy
- •6.8 Central Abnormalities of Vergence and Gaze
- •6.8.1 Developmental Esotropia and Exotropia
- •6.8.2 Cerebellar Disease
- •6.8.3 Horizontal Gaze Palsy and Progressive Scoliosis
- •References
- •7.1 Congenital Cranial Dysinnervation Disorders: Facts About Ocular Motility Disorders
- •7.1.1 The Concept of CCDDs: Ocular Motility Disorders as Neurodevelopmental Defects
- •7.1.1.1 Brainstem and Cranial Nerve Development
- •7.1.1.2 Single Disorders Representing CCDDs
- •7.1.1.3 Disorders Understood as CCDDs
- •7.2 Congenital Cranial Dysinnervation Disorders: Perspectives to Understand Ocular Motility Disorders
- •7.2.1.1 Brown Syndrome
- •Motility Findings
- •Saccadic Eye Movements
- •Comorbidity
- •Epidemiologic Features
- •Laterality
- •Sex Distribution
- •Incidence
- •Heredity
- •Potential Induction of the Syndrome
- •Radiologic Findings
- •Natural Course in Brown Syndrome
- •Intra-and Postoperative Findings
- •References
- •8.1 Amblyopia
- •8.2 What Is Screening?
- •8.2.1 Screening for Amblyopia, Strabismus, and/or Refractive Errors
- •8.2.1.1 Screening for Amblyopia
- •8.2.1.2 Screening for Strabismus
- •8.2.1.3 Screening for Refractive Error
- •8.2.1.4 Screening for Other Ocular Conditions
- •8.3 Screening Tests for Amblyopia, Strabismus, and/or Refractive Error
- •8.3.1 Vision Tests
- •8.3.3 Stereoacuity
- •8.3.4 Photoscreening and/or Autorefraction
- •8.3.6 Who Should Administer the Screening Program?
- •8.4 Treatment of Amblyopia
- •8.4.1 Type of Treatment
- •8.4.2 Refractive Adaptation
- •8.4.3 Conventional Occlusion
- •8.4.4 Pharmacological Occlusion
- •8.4.5 Optical Penalization
- •8.4.7 Treatment Compliance
- •8.4.8 Other Treatment Options for Amblyopia
- •8.4.9 Recurrence of Amblyopia Following Therapy
- •8.5 Quality of Life
- •8.5.1 The Impact of Amblyopia Upon HRQoL
- •8.5.3 Reading Speed and Reading Ability in Children with Amblyopia
- •8.5.4 Impact of Amblyopia Upon Education
- •8.5.6 The Impact of Strabismus Upon HRQoL
- •8.5.7 Critique of HRQoL Issues in Amblyopia
- •8.5.8 The Impact of the Condition or the Impact of Treatment?
- •References
- •9. The Brückner Test Revisited
- •9.1 Amblyopia and Amblyogenic Disorders
- •9.1.1 Early Detection of Amblyopia
- •9.1.2 Brückner’s Original Description
- •9.2.1 Physiology
- •9.2.2 Performance
- •9.2.3 Shortcomings and Pitfalls
- •9.3.1 Physiology
- •9.3.2 Performance
- •9.3.3 Possibilities and Limitations
- •9.4.1 Physiology
- •9.4.2 Performance
- •9.4.3 Possibilities and Limitations
- •9.5 Eye Movements with Alternating Illumination of the Pupils
- •References
- •10. Amblyopia Treatment 2009
- •10.1 Amblyopia Treatment 2009
- •10.1.1 Introduction
- •10.1.2 Epidemiology
- •10.1.3 Clinical Features of Amblyopia
- •10.1.4 Diagnosis of Amblyopia
- •10.1.5 Natural History
- •10.2 Amblyopia Management
- •10.2.1 Refractive Correction
- •10.2.2 Occlusion by Patching
- •10.2.3 Pharmacological Treatment with Atropine
- •10.2.4 Pharmacological Therapy Combined with a Plano Lens
- •10.3 Other Treatment Issues
- •10.3.1 Bilateral Refractive Amblyopia
- •10.3.3 Maintenance Therapy
- •10.4 Other Treatments
- •10.4.1 Filters
- •10.4.2 Levodopa/Carbidopa Adjunctive Therapy
- •10.5 Controversy
- •10.5.1 Optic Neuropathy Rather than Amblyopia
- •References
- •11.1 Introduction
- •11.1.2 Sensory or Motor Etiology
- •11.1.4 History
- •11.1.5 Outcome Parameters
- •11.2 Outcome of Surgery in the ELISSS
- •11.2.1 Reasons for the ELISSS
- •11.2.2 Summarized Methods of the ELISSS
- •11.2.3 Summarized Results of the ELISSS
- •11.2.4 Binocular Vision at Age Six
- •11.2.5 Horizontal Angle of Strabismus at Age Six
- •11.2.6 Alignment is Associated with Binocular Vision
- •11.3 Number of Operations and Spontaneous Reduction into Microstrabismus Without Surgery
- •11.3.1 The Number of Operations Per Child and the Reoperation Rate in the ELISSS
- •11.3.2 Reported Reoperation Rates
- •11.3.3 Test-Retest Reliability Studies
- •11.3.6 Spontaneous Reduction of the Angle
- •11.3.7 Predictors of Spontaneous Reduction into Microstrabismus
- •Appendix
- •References
- •12.1 Overview
- •12.1.2 Manifest Latent Nystagmus (MLN)
- •12.1.2.1 Clinical Characteristics of Manifest Latent Nystagmus (MLN)
- •12.1.3 Congenital Periodic Alternating Nystagmus (PAN)
- •12.1.3.1 Clinical characteristics of congenital periodic alternating nystagmus
- •12.2 Compensatory Mechanisms
- •12.2.1 Dampening by Versions
- •12.2.2 Dampening by Vergence
- •12.2.3 Anomalous Head Posture (AHP)
- •12.2.3.4 Measurement of AHP
- •12.2.3.6 Testing AHP at Near
- •12.3 Treatment
- •12.3.1 Optical Treatment
- •12.3.1.1 Refractive Correction
- •12.3.1.2 Spectacles and Contact Lenses (CL)
- •12.3.1.3 Prisms
- •12.3.1.4 Low Visual Aids
- •12.3.2 Medication
- •12.3.3 Acupuncture
- •12.3.4 Biofeedback
- •12.3.6 Surgical Treatment of Congenital Nystagmus
- •12.3.6.1 Management of Horizontal AHP
- •12.3.6.2 Management of Vertical AHP
- •12.3.6.3 Management of Head Tilt
- •Retro-Equatorial Recession of Horizontal Rectus Muscles
- •The Tenotomy Procedure
- •References
- •13.1 Dissociated Deviations
- •13.2 Surgical Alternatives to Treat Patients with DVD
- •13.2.1 Symmetric DVD with Good Bilateral Visual Acuity, with No Oblique Muscles Dysfunction
- •13.2.2 Bilateral DVD with Deep Unilateral Amblyopia
- •13.2.3 DVD with Inferior Oblique Overaction (IOOA) and V Pattern
- •13.2.4 DVD with Superior Oblique Overaction (SOOA) and A Pattern
- •13.2.5 Symmetric vs. Asymmetric Surgeries for DVD
- •13.3 Dissociated Horizontal Deviation
- •13.4 Dissociated Torsional Deviation. Head tilts in patients with Dissociated Strabismus
- •13.5 Conclusions
- •References
- •14.1 Introduction
- •14.2 Clinical and Theoretical Investigations
- •References
- •15.1 General Principles of Surgical Treatment in Paralytic Strabismus
- •15.1.1 Aims of Treatment
- •15.1.2 Timing of Surgery
- •15.1.3 Preoperative Assessment
- •15.1.4 Methods of Surgical Treatment
- •15.2 Third Nerve Palsy
- •15.2.1 Complete Third Nerve Palsy
- •15.2.2 Incomplete Third Nerve Palsy
- •15.3 Fourth Nerve Palsy
- •15.4 Sixth Nerve Palsy
- •References
- •16.1 Graves Orbitopathy (GO): Pathogenesis and Clinical Signs
- •16.1.1 Graves Orbitopathy is Part of a Systemic Disease: Graves Disease (GD)
- •16.1.2 Graves Orbitopathy−Clinical Signs
- •16.1.2.1 Clinical Changes Result in Typical Symptoms
- •16.1.3 Clinical Examination of GO
- •16.1.3.1 Signs of Activity
- •16.1.3.2 Assessing Severity of GO
- •16.1.3.3 Imaging
- •16.2 Natural History
- •16.3 Treatment of GO
- •16.3.1.1 Glucocorticoid Treatment
- •16.3.1.2 Orbital Radiotherapy
- •16.3.1.3 Combined Therapy: Glucocorticoids and Orbital Radiotherapy
- •16.3.1.4 Other Immunosuppressive Treatments and New Developments
- •16.3.2 Inactive Disease Stages
- •16.3.2.1 Orbital Decompression
- •16.3.2.2 Extraocular Muscle Surgery
- •16.3.2.3 Lid Surgery
- •16.4 Thyroid Dysfunction and GO
- •16.5.1 Relationship Between Cigarette Smoking and Graves Orbitopathy
- •16.5.2 Genetic Susceptibility
- •16.6 Special Situations
- •16.6.1 Euthyroid GO
- •16.6.2 Childhood GO
- •16.6.3 GO and Diabetes
- •References
100 |
8 The Value of Screening for Amblyopia Revisited |
Summary for the Clinician
■ The purpose of screening is to identify persons as being at greater or lesser risk of developing, or
8having a particular condition. Screening should be considered in terms of the condition, diagnosis, treatment, and the screening program itself.
■Vision screening for children may be considered in terms of detection of amblyopia, strabismus, and/or refractive error. Variations exist within and between countries regarding vision screening for children in terms of program content, referral criteria, and personnel.
■The justifications of vision screening for children include an increased risk of blindness to the healthy eye as a result of injury or disease in adults with amblyopia.
■An increased risk of blindness is present, as the non-amblyopic eye of an amblyope may become diseased or injured.
■Recent reports indicate that further evidence is required to support the notion of pre-school vision screening despite seminal research examining diagnosis, treatment, and consequence of amblyopia, strabismus, and/or refractive error.
8.3Screening Tests for Amblyopia, Strabismus, and/or Refractive Error
The accurate detection of amblyopia, strabismus, and/or refractive error undoubtedly forms a critical factor in the reported success of any pre-school vision screening program. However, much variation exists both within and between countries as to the content of vision screening programs. This includes the age at which the child is screened, referral criteria of the screening program, and indeed, the personnel administering the tests that form the screening program. Owing to such di erences, it is often di cult to make direct comparisons between studies that report on vision screening success. Much has been contributed to the literature over recent years,largely through the work of the Vision in Preschoolers Study (VIP). VIP is a multi-centre study, conducted in the USA, whose purpose is to evaluate whether there are tests, or combinations of tests, that can be used e ectively in preschool vision testing.
The e ectiveness of a screening test in detecting a condition is considered in terms of sensitivity, specificity, and positive and negative predictive values. Sensitivity is defined as the proportion of individuals with the target
condition in a population who are correctly identified by a screening test. Specificity is the proportion of individuals free of the target condition in a population who are correctly identified by a screening test. Positive predictive values describe the proportion of individuals with a positive result who have a target condition; and negative predictive value is the proportion of individuals who test negative and who do not have a target condition.
8.3.1 Vision Tests
The use of crowded logMAR acuity is the gold-standard VA measure in adults both within clinical and research settings. This is also becoming the case with VA measurement in children. Steps have been made to identify normative values of pediatric VA using di erent vision tests, protocols of testing, and repeatability of testing [15–19]. The preference as to which vision test that is to be included in a screening program is not always clear. Often a number of vision tests may be included within the one screening program to incorporate factors such as a child’s comprehension and ability to perform a test. It is outside the scope of this chapter to report upon the relative sensitivity and specificity of each vision test. However, it should be noted that the cut-o points used for referral within a screening program should be directly related to the specific vision tests used within that screening program. In other words, it should not be generic, with an arbitrary referral point (such as 0.2 logMAR or worse). A VA level that is achieved using one vision test may be di erent from that achieved using an alternative vision test. The referral criteria should be stipulated for each vision test that could be used within the screening program.
8.3.2Cover-Uncover Test
The cover-uncover test is used to detect the presence of strabismus, and is deemed to be the gold standard for detecting strabismus. However, there are few studies that report on the sensitivity and specificity of the test itself. Williams et al. [20] were able to report on the sensitivity and specificity of the cover-uncover test on children who had been screened at the ages of 8, 12, 18, 25, 31 and 37 months. At 37 months, the sensitivity of the test was calculated to be 75% (95% CI, 0.577–0.899%), with a specificity of 100%.
The VIP study also assessed the e ectiveness of the cover-uncover test in detecting strabismus, amblyopia, reduced VA, and refractive error [21]. The results are
|
8.3 Screening Tests for Amblyopia, Strabismus, and/or Refractive Error |
101 |
|||
Table 8.2. Sensitivity of cover-uncover test when specificity was set to 0.94 [21] |
|
|
|||
Test |
Amblyopia n = 75 |
Strabismus n = 48 |
Refractive error |
Reduced VA n = 132 |
|
|
(95% CI) |
(95% CI) |
n = 240 (95% CI) |
(95% CI) |
|
Cover-uncover |
0.27 (0.17–0.37) |
0.60 (0.46–0.74) |
0.16 (0.11–0.21) |
0.06 (0.02–0.10) |
|
n = number of children |
|
|
|
|
|
summarized in Table 8.2. The results of this study indicated that the cover-uncover test is more sensitive at detecting the presence of strabismus compared with detecting the presence of amblyopia, refractive error, or reduced VA.
8.3.3Stereoacuity
The inclusion of stereoacuity tests within pre-school vision screening programs could be considered as a contentious issue. VIP [22] stated that most guidelines recommend a test of stereopsis. However, if a child was found to have normal VA, no strabismus, and no clinically significant refractive error, yet failed to demonstrate adequate evidence of stereoacuity, should they be referred for further investigation? A number of stereotests are available for use as part of a pre-school vision screening program; however, normative pediatric values of stereopsis have not been identified for some of these tests. In the absence of such data, the appropriateness of inclusion of such tests could be questioned. Stereotests that involve a pass/fail response could be deemed as more appropriate for the purpose of screening for vision problems.
The VIP has reported on the testability of two di erent stereotests used to screen for vision disorders,the Random Dot E and the Stereo Smile test [21, 23]. The results reported by condition type are summarized in Table 8.3. The results indicated that both the stereotests are more accurate at detecting the presence of amblyopia and strabismus compared with that for reduced VA or refractive error.
In a further study, VIP examined the sensitivity of the same stereotests when the specificity was set at 0.94. The results are summarized in Table 8.4, and show that the Stereo Smile test was more accurate than the Random Dot E in detecting most target conditions of screening.
8.3.4Photoscreening and/or Autorefraction
The use of photoscreeners and/or autorefractors in pre-school vision screening is extremely varied. Within the USA, they are commonplace, and the variety of different makes and models make summarizing literature extremely di cult. The use of such instruments within
Table 8.3. Sensitivity of Random Dot E and stereo smile by condition typea [23] |
|
|
|||
Stereotest |
Amblyopia |
Reduced VA |
Strabismus |
Refractive error |
Specificity |
Year 1 n = 796 |
n = 75 |
n = 132 |
n = 48 |
n = 240 |
|
Random Dot E |
0.63 |
0.38 |
0.60 |
0.47 |
0.90 |
Year 2 n = 1037 |
n = 88 |
n = 114 |
n = 62 |
n = 299 |
|
Stereo smile |
0.77 |
0.30 |
0.68 |
0.51 |
0.91 |
n = number of children; amay have more than one condition |
|
|
||
Table 8.4. Sensitivity of Random Dot E and stereo smile when specificity was set to 0.94a [21] |
|
|||
Test |
Amblyopia |
Strabismus |
Refractive error |
Reduced VA |
|
(95% CI) |
(95% CI) |
(95% CI) |
(95% CI) |
Random Dot E |
0.28 (0.18–0.38) |
0.29 (0.16–0.42) |
0.23 (0.18–0.23) |
0.24 (0.17–0.31) |
Stereo smile |
0.61 (0.51–0.71) |
0.58 (0.46–0.70) |
0.37 (0.32–0.42) |
0.20 (0.13–0.27) |
aMay have more than one condition
102 |
8 The Value of Screening for Amblyopia Revisited |
UK pre-school vision screening programs is much less frequent. When considering the appropriateness of photoscreeners and/or autorefractors in pre-school vision screening, it is important to recognize their accuracy
8when compared with a gold standard (usually a refraction performed under full cycloplegia). There are notable advantages and disadvantages of photoscreening when compared with autorefraction. One of the main di erences is that of cost. After the initial expense of purchase, there is minimal additional cost to autorefraction. Photoscreening, however, requires printing of the image, and depending upon who is administering the test, interpretation of the results. The implications of both these factors lead to a higher overall expense when incorporated into a vision screening program.
It should also be noted that the primary aim of the use of a photoscreener or autorefractor is the detection of refractive error. That is, it may detect an amblyogenic factor, but not amblyopia itself. Similarly, the presence of strabismus may also be detected, although understandably, the sensitivity and specificity rates of these are considerably lower than those of detecting refractive error.
It is beyond the scope of this chapter to review and appraise literature describing specific photorefractors and/or autorefractors. Important points to note when considering such articles include the study population (including age, ethnicity, and whether general or clinical); test setting (e.g. environment); sensitivity and specificity of the test; the personnel conducting the test; and whether any comparison is made to the gold standard (in this case, full refraction under cycloplegia).
8.3.5What to Do with Those Who
Are Unable to Perform Screening Tests?
Successful testing of children is largely dependent on the child’s cooperation and compliance. The decision about whether to refer those children who are unable to perform screening tests is di cult. Some would argue that such children ought to be referred for further investigation, for the reason that they are unable to perform the screening tests due to the presence of an ocular condition. Others would say that this may not be the case, and that cooperation may be the true issue. The prevalence of ocular conditions amongst children who were unable to perform pre-school screening tests has been investigated and it was found that pre-school children who were unable to perform the screening test were at a higher risk of higher amblyopia, strabismus, significant refractive error, or unexplained low VA compared with those who had passed the screening test [24]. This led the authors to
recommend that these children ought to be referred or retested at a later date possibly with a di erent test. The impact of recall and re-testing, or automatic referral will undoubtedly a ect the overall clinical and cost e ectiveness of any pre-school vision program.
8.3.6Who Should Administer the Screening Program?
Within the UK, it is recommended that pre-school vision screening programs be conducted by orthoptists or by professionals trained and supported by orthoptists [3, 4]. In the USA, pre-school vision screening is usually conducted by nurses and lay people. The use of lay people to administer screening tests does have advantages, particularly when considering the economic burden of a screening program. Lay screeners are a cheaper alternative to eye care professionals, such as orthoptists, optometrists, or ophthalmologists.
Concerns regarding training and assessment of lay screeners have been raised; are lay screeners as accurate as eye care professionals in detecting amblyopia, strabismus, and/or refractive error? This question was addressed by VIP, who assessed the performance of lay screeners in administering pre-school vision screening tests compared to nurse screeners [25]. In this study, the screening tests conducted included assessment of refractive error, VA, and stereoacuity. Two hand-held autorefractors were used to detect the presence of refractive error. VA was assessed at two di erent testing distances; a linear test was performed at 10 feet, and a single, crowded test administered at 5 feet. The results of the study demonstrated that although nurse screeners appeared to have slightly higher sensitivities in the assessment of refractive error and presence of stereoacuity compared with lay screeners, the differences were not statistically significant.
However, when examining the results of VA testing, the authors reported that nurse screeners achieved significantly higher sensitivity than lay screeners with the linear VA test. Whilst the authors made no recommendations for future screening protocol strategies, their results could be interpreted in two ways. The lack of statistically significant di erences in detection of refractive error or stereoacuity with tests administered by lay screeners could support the use of such personnel in vision screening programs. However, the di erences observed in VA testing between lay screeners and nurse screeners could suggest that nurse screeners would be more e ective in detecting vision anomalies. Di erences in screening programs between countries will undoubtedly continue to exist; however, recommendations as to
